Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128596) titled 'Evaluation of the effect of dexamethasone regimen in preventing vomiting in patients undergoing immunotherapy combined chemotherapy' on July 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Anqing first People's Hospital
Condition:
Malignant tumor, vomiting
Intervention:
Control group (including dexamethasone group):None
Other solution group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-27
Target Sample Size: Control group (including dexamethasone group):112;Other solution group:53;Exposure group (the group without dexamethasone):112; ...